Cite Filings / RCKT / 0001140361-25-032012

Feed Companies Filings Check

Sign in

8-K

Current Report

ROCKET PHARMACEUTICALS, INC. Filed 2025-08-20 Acc 0001140361-25-032012

Other events

Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

8-K Current Report , ef20054253_8k.htm

Around this filing

2025-08-25 8-K Executive or director change
2025-08-20 4 See Remarks sold 1,060 shares at an average $3.04 ($3,224)
2025-08-20 4 See Remarks sold 2,485 shares at an average $3.04 ($7,561)
2025-08-20 4 General Counsel sold 1,592 shares at an average $3.04 ($4,839)
2025-08-20 4 CEO gave up 2,234 shares (to pay taxes)
2025-08-20 8-K Other events
2025-08-07 8-K Results of operations · Executive or director change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading ef20054253_8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…